What Are Analysts Report About Zosano Pharma Corp. (ZSAN)


Zosano Pharma Corporation (ZSAN) will report its next earnings on May 10 – May 15 (Est.). The company reported the earnings of $-0.46/Share in the last quarter where the estimated EPS by analysts was $-0.45/share. The difference between the expected and actual EPS was $-0.01/share, which represents an Earnings surprise of -2.2%.

Many analysts are providing their Estimated Earnings analysis for Zosano Pharma Corporation and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.43/share. These analysts have also projected a Low Estimate of $-0.43/share and a High Estimate of $-0.43/share.

Some buy side analysts are also providing their Analysis on Zosano Pharma Corporation, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 1 Analysts reported that the Price Target for Zosano Pharma Corporation might touch $3.25 high while the Average Price Target and Low price Target is $3.25 and $3.25 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Zosano Pharma Corporation got Downgrade on 11-Aug-16 where investment firm Ladenburg Thalmann Downgrade the stock from Buy to Neutral.

Zosano Pharma Corporation closed its last trading session at $1.72 with the loss of -9.88%. The Market Capitalization of the company stands at 30.1 Million. The Company has 52-week high of $3.54 and 52-week low of $0.45. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -37.53% where SMA50 and SMA200 are -10.68% and 30.2% respectively. The Company Touched its 52-Week High on Feb 16, 2017 and 52-Week Low on Nov 3, 2016.

The Relative Volume of the company is 3.77 and Average Volume (3 months) is 3.08 million. Zosano Pharma Corporation P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -100.2%. The Return on Equity (ROE) value stands at -249.6%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Zosano Pharma Corporation currently shows a Weekly Performance of -34.04%, where Monthly Performance is -45.61%, Quarterly performance is 68.48%, 6 Months performance is 104.67% and yearly performance percentage is -41.95%. Year to Date performance value (YTD perf) value is 98.72%. The Stock currently has a Weekly Volatility of 12.05% and Monthly Volatility of 15.09%.